RRE Ventures Acquisition Corp. president Jeffrey Douglas Epstein reported awards of warrants and founder shares. He received 500,000 private placement warrants at a purchase price of $1.0000 per warrant, each exercisable for Class A Ordinary Shares at a conversion price of $11.5000.
He was also granted 450,000 Class B Ordinary Shares on March 2, 2026 and a further 150,000 Class B Ordinary Shares on March 18, 2026, bringing his Class B holdings to 600,000 shares. According to the filing, the Class B Ordinary Shares will automatically convert into Class A Ordinary Shares on a one-for-one basis upon the issuer’s initial business combination, or earlier at his option.
RRE Ventures Acquisition Corp. director awards via affiliated LLC show compensation-style grants rather than open-market trades. Keegan Investment Holdings, LLC, an entity associated with director Brian Frederick Daly, received 250,000 private placement warrants at $1.00 each, exercisable for Class A Ordinary Shares at $11.50 per share after the company’s initial business combination. The same LLC also received 75,000 and then an additional 30,000 Class B Ordinary Shares, which are convertible into Class A Ordinary Shares on a one-for-one basis with no expiration.
RRE Ventures Acquisition Corp. director Bruce Bernstein reported receiving equity awards in the form of warrants and Class B Ordinary Shares. On May 1, 2026, he was granted 250,000 warrants at $1.00 per warrant, each exercisable into one Class A Ordinary Share at a conversion price of $11.50 per share, bringing his warrant holdings to 250,000. Earlier awards of Class B Ordinary Shares on March 2, 2026 for 40,000 shares and on March 25, 2026 for 75,000 shares increased his Class B holdings to 115,000. The Class B shares automatically convert into Class A Ordinary Shares on a one-for-one basis at the time of the company’s initial business combination, or earlier at his option, while the private placement warrants become exercisable 30 days after that business combination and expire five years later.
RRE Ventures Acquisition Corp. director Robert Scott Mancini reported awards of derivative securities linked to Class A Ordinary Shares. He received 250,000 warrants at $1.00 per warrant, each exercisable into one Class A share at an exercise price of $11.50 after the company’s initial business combination. He also received 75,000 and 40,000 Class B Ordinary Shares at no cost, which automatically convert into Class A shares on a one-for-one basis in connection with the initial business combination or earlier at his option.
RRE Ventures Acquisition Corp. director and CEO Philip Kassin reported awards of warrants and convertible sponsor shares rather than open‑market trades. He received 250,000 private placement warrants at $1.00 per warrant, each exercisable for one Class A Ordinary Share at $11.50 per share. Earlier awards added 450,000 and 75,000 Class B Ordinary Shares, which are convertible into Class A on a one‑for‑one basis in connection with the company’s initial business combination. After these grants, he directly holds 250,000 warrants and 525,000 Class B shares, with no sales or dispositions reported.
RRE Ventures Acquisition Corp. director James Steven Gertler reported compensation-related equity grants. He received 125,000 private placement warrants on May 1, 2026 at $1.00 per warrant, each exercisable for one Class A Ordinary Share at an exercise price of $11.50. He was also awarded 30,000 Class B Ordinary Shares on March 2, 2026 and a further 37,500 Class B Ordinary Shares on March 24, 2026, taking his Class B holdings to 67,500 shares. The Class B Ordinary Shares automatically convert into Class A Ordinary Shares on a one-for-one basis at the company’s initial business combination, or earlier at his option, and the private placement warrants become exercisable 30 days after that business combination and expire five years later or earlier upon liquidation.
RRE Ventures Acquisition Corp. is conducting an initial public offering of 25,000,000 units at $10.00 per unit for aggregate gross proceeds of $250,000,000. Each unit contains one Class A ordinary share and one-third of a redeemable warrant; whole warrants exercise at $11.50.
The offering proceeds (including the over-allotment if exercised) will place $250.0 million (or $287.5 million with full over-allotment) into a U.S.-based trust account pending an initial business combination. The sponsor will purchase 4,510,000 private placement warrants at $1.00 each; the underwriters may buy up to 3,750,000 additional units to cover over-allotments.
RRE Ventures Acquisition Corp. director Kendrick Brett Meek reported beneficial ownership of 30,000 Class B Ordinary Shares on this Form 3. These Class B shares are convertible into 30,000 Class A Ordinary Shares on a one-for-one basis, either automatically at the company’s initial business combination or earlier at his option, and they have no expiration date.
RRE Ventures Acquisition Corp. director and Chief Executive Officer Philip Kassin reported his initial ownership on a Form 3. He holds 525,000 Class B Ordinary Shares, which are structured to automatically convert into Class A Ordinary Shares on a one-for-one basis in connection with the company’s initial business combination or earlier at his option.
The footnote explains these Class B shares have no expiration date and will convert into an equal number of Class A shares, subject to adjustment. The filing does not report any new purchases or sales, but establishes Kassin’s starting equity position in the sponsor shares of the acquisition vehicle.
RRE Ventures Acquisition Corp. Chief Financial Officer Andrew Albert Kucharchuk filed an initial ownership report showing holdings of Class B Ordinary Shares. The filing indicates that 25,000 Class B shares are directly owned and are convertible into 25,000 Class A Ordinary Shares on a one-for-one basis at an exercise price of $0.0000 per share. According to the footnote, these Class B shares will automatically convert into Class A shares at the time of the company’s initial business combination, or earlier at the reporting person’s option, and they have no expiration date.